Use Of Cannabidiol In The Treatment Of Epilepsy

  • Published: Jan 12, 2017
  • Earliest Priority: Jun 17 2014
  • Family: 39
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info: Full text

The present disclosurerelates to the use of cannabidiol (CBD) in the treatment of absence seizures. In particular, the disclosure relates to the use of CBD for reducing absence seizures in patients suffering withetiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; CDKL5; Dup15q;, Jeavons syndrome; Myoclonic Absence Epilepsy;Neuronal ceroid lipofuscinoses(NCL) and brain abnormalities. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).

CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 12, 2017
  • Application: Jun 17, 2015
    AU AU 2015/275887 A
  • Priority: Jun 17, 2015
    GB GB 2015051776 W
  • Priority: Jun 17, 2014
    GB GB 201410771 A

Sign in to the Lens